CA2796412A1 — Method for treating scars with adapalene 0.3%
Assigned to Galderma Research and Development SNC · Expires 2011-11-03 · 15y expired
What this patent protects
The present invention is a method for treating at least one scar where an effective amount of adapalene is administrated to the patient in need thereof, adapalene or its salts. Preferably Adapalene is in a quantity of 0.3% of weight relative to the total weight of the composition…
USPTO Abstract
The present invention is a method for treating at least one scar where an effective amount of adapalene is administrated to the patient in need thereof, adapalene or its salts. Preferably Adapalene is in a quantity of 0.3% of weight relative to the total weight of the composition.
Drugs covered by this patent
- Differin (ADAPALENE) · Galderma Labs Lp
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.